MeSH term
Frequency | Condition_Probility | Agrin/*physiology | 7 | 100.0 |
English Abstract | 3 | 0.0 |
Humans | 46 | 0.0 |
Neuromuscular Junction/*physiology | 4 | 22.0 |
Synapses/*physiology | 6 | 17.0 |
Animals | 77 | 0.0 |
Cells, Cultured | 17 | 0.0 |
Cytoskeletal Proteins/metabolism | 4 | 1.0 |
Dystroglycans | 6 | 12.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
Membrane Glycoproteins/metabolism | 4 | 0.0 |
Muscle Proteins/*metabolism | 2 | 4.0 |
Phosphorylation/drug effects | 4 | 0.0 |
Quinones/pharmacology | 2 | 1.0 |
Receptor Protein-Tyrosine Kinases/metabolism | 9 | 3.0 |
Receptors, Cholinergic/*metabolism | 11 | 61.0 |
Research Support, Non-U.S. Gov't | 62 | 0.0 |
Signal Transduction/physiology | 7 | 0.0 |
Staurosporine/pharmacology | 2 | 1.0 |
Tyrosine/metabolism | 9 | 0.0 |
Utrophin | 4 | 15.0 |
Adult | 9 | 0.0 |
Male | 18 | 0.0 |
Agrin/*metabolism | 7 | 87.0 |
COS Cells | 7 | 0.0 |
Cell Differentiation/*physiology | 3 | 1.0 |
Glycosylation | 2 | 0.0 |
Muscles/metabolism | 3 | 3.0 |
Presynaptic Terminals/metabolism/ultrastructure | 2 | 33.0 |
Protein Structure, Tertiary/physiology | 2 | 1.0 |
Receptors, Cholinergic/metabolism | 10 | 50.0 |
Research Support, U.S. Gov't, P.H.S. | 40 | 0.0 |
Macromolecular Substances | 4 | 0.0 |
Mice | 32 | 0.0 |
Models, Neurological | 3 | 2.0 |
Muscle Proteins/physiology | 2 | 18.0 |
Neuromuscular Junction/*physiology/ultrastructure | 2 | 66.0 |
Neurons/physiology | 3 | 2.0 |
Receptor Protein-Tyrosine Kinases/physiology | 4 | 8.0 |
Receptors, Cholinergic/physiology | 3 | 37.0 |
Receptors, Growth Factor/physiology | 2 | 4.0 |
Signal Transduction | 9 | 0.0 |
Synapses/*physiology/ultrastructure | 2 | 40.0 |
src-Family Kinases/physiology | 2 | 6.0 |
Amino Acid Sequence | 10 | 0.0 |
Molecular Sequence Data | 17 | 0.0 |
Multigene Family | 3 | 0.0 |
Mutation/genetics | 3 | 0.0 |
Protein Structure, Tertiary | 6 | 0.0 |
Receptor Protein-Tyrosine Kinases/*chemistry/genetics/*metabolism | 3 | 42.0 |
Receptor Protein-Tyrosine Kinases/*physiology | 3 | 4.0 |
*Receptors, Cholinergic | 12 | 100.0 |
Dimerization | 3 | 0.0 |
Enzyme Activation | 9 | 0.0 |
Neuraminidase/pharmacology | 4 | 5.0 |
Neuromuscular Junction/physiology | 3 | 37.0 |
Phosphorylation | 20 | 0.0 |
Receptors, Cholinergic/*physiology | 2 | 22.0 |
Synapses/physiology | 4 | 10.0 |
Transfection | 14 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Green Fluorescent Proteins | 3 | 0.0 |
Ligands | 2 | 0.0 |
Models, Biological | 4 | 0.0 |
Muscle Proteins/genetics/metabolism | 4 | 23.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Receptor Protein-Tyrosine Kinases/genetics/*metabolism | 9 | 7.0 |
Receptors, Cholinergic/*genetics | 3 | 18.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Female | 16 | 0.0 |
Gene Deletion | 3 | 0.0 |
Gene Expression Regulation, Developmental | 4 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Luminescent Proteins/genetics | 2 | 1.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 2 | 0.0 |
Synapses/enzymology | 2 | 33.0 |
Xenopus laevis | 4 | 0.0 |
Agrin/metabolism/pharmacology | 3 | 75.0 |
In Situ Hybridization | 4 | 0.0 |
Muscle Fibers/metabolism | 3 | 16.0 |
Neuromuscular Junction/*enzymology | 3 | 50.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Rats | 17 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Binding Sites | 5 | 0.0 |
Proto-Oncogene Proteins/metabolism | 5 | 0.0 |
Synapses/metabolism | 2 | 10.0 |
*Gene Expression Regulation, Developmental | 4 | 0.0 |
Receptor Protein-Tyrosine Kinases/*genetics/metabolism | 2 | 3.0 |
Axons/physiology | 2 | 4.0 |
Mice, Knockout | 8 | 0.0 |
Motor Neurons/*physiology | 2 | 3.0 |
Muscle Denervation | 3 | 27.0 |
Agrin/metabolism | 5 | 83.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Protein Binding | 5 | 0.0 |
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 1.0 |
Cell Line | 16 | 0.0 |
Muscle, Skeletal/cytology/metabolism | 2 | 11.0 |
Precipitin Tests | 3 | 0.0 |
Quail | 3 | 7.0 |
Agrin/physiology | 4 | 100.0 |
Cell Differentiation | 3 | 0.0 |
Muscle Development | 2 | 7.0 |
Autoantibodies/*blood | 3 | 1.0 |
Receptor Protein-Tyrosine Kinases/*immunology | 7 | 41.0 |
Receptors, Cholinergic/*immunology | 8 | 42.0 |
Gene Expression Regulation, Developmental/physiology | 2 | 2.0 |
Receptors, Cholinergic/genetics/*metabolism | 4 | 100.0 |
Chick Embryo | 3 | 0.0 |
Chickens/*genetics | 2 | 2.0 |
*Gene Expression Regulation, Enzymologic | 3 | 0.0 |
Muscle Fibers/cytology/enzymology | 2 | 66.0 |
Receptor Protein-Tyrosine Kinases/chemistry/*genetics | 2 | 11.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
Species Specificity | 2 | 0.0 |
Transcription, Genetic/physiology | 2 | 1.0 |
Receptor Protein-Tyrosine Kinases/genetics/metabolism | 2 | 3.0 |
DNA, Complementary | 2 | 0.0 |
Gene Expression/physiology | 4 | 1.0 |
Torpedo | 4 | 10.0 |
Antibodies/metabolism | 2 | 2.0 |
Antibody Specificity | 5 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Laminin/metabolism | 2 | 1.0 |
Microscopy, Electron | 2 | 0.0 |
Neuromuscular Junction/*metabolism/ultrastructure | 2 | 66.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 8 | 0.0 |
Agrin/pharmacology/*physiology | 2 | 100.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Muscle Proteins/*physiology | 3 | 30.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Signal Transduction/*physiology | 6 | 0.0 |
Aged | 6 | 0.0 |
Child, Preschool | 4 | 0.0 |
Comparative Study | 7 | 0.0 |
Immunosuppressive Agents/therapeutic use | 4 | 1.0 |
Middle Aged | 9 | 0.0 |
Rats, Sprague-Dawley | 3 | 0.0 |
Receptor Protein-Tyrosine Kinases/*metabolism | 8 | 3.0 |
Phosphotyrosine/metabolism | 3 | 0.0 |
*Signal Transduction | 4 | 0.0 |
Adenosine Triphosphate/metabolism | 2 | 0.0 |
Cell Fusion | 2 | 0.0 |
Mutation | 3 | 0.0 |
Gene Expression | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/genetics/*physiology | 2 | 7.0 |
Receptors, Nicotinic/*physiology | 2 | 28.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Muscle, Skeletal/*physiology | 2 | 2.0 |
Transcription, Genetic | 2 | 0.0 |
Adrenal Cortex Hormones/therapeutic use | 2 | 2.0 |
Autoantigens/*immunology | 5 | 3.0 |
Thymectomy | 3 | 10.0 |
Adolescent | 4 | 0.0 |
Autoantibodies/*blood/immunology | 2 | 8.0 |
Child | 4 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Muscle Weakness/etiology/immunology | 2 | 100.0 |
Nerve Tissue Proteins/immunology | 2 | 20.0 |
Plasma Exchange | 2 | 9.0 |
Plasmapheresis | 2 | 5.0 |
Cysteine | 2 | 1.0 |
Databases, Factual | 2 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
Drosophila melanogaster | 2 | 1.0 |
Insect Hormones/chemistry | 2 | 66.0 |
Membrane Proteins/*chemistry | 2 | 4.0 |
Receptor Protein-Tyrosine Kinases/*chemistry/classification | 2 | 100.0 |
Receptors, Cell Surface/chemistry/classification | 2 | 100.0 |
Sequence Alignment | 2 | 0.0 |
*Zebrafish Proteins | 3 | 1.0 |
Blotting, Northern | 3 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Receptors, Cholinergic/analysis | 2 | 40.0 |
Base Sequence | 4 | 0.0 |
Receptor Aggregation | 6 | 6.0 |
Receptor Protein-Tyrosine Kinases/chemistry/*genetics/metabolism | 2 | 22.0 |
Agrin/pharmacology | 3 | 60.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Synapses/metabolism/*physiology | 2 | 50.0 |
Blotting, Western | 2 | 0.0 |
Bungarotoxins/metabolism | 2 | 22.0 |
Protein-Tyrosine Kinase/metabolism | 2 | 0.0 |
Muscle Proteins/metabolism | 2 | 4.0 |
Tissue Distribution | 2 | 0.0 |
Pregnancy | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Myasthenia Gravis/*blood | 2 | 40.0 |
Biological Markers/blood | 2 | 0.0 |
Neuromuscular Junction/genetics/*metabolism | 2 | 66.0 |
Synapses/genetics/*metabolism | 2 | 66.0 |
Conserved Sequence | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/chemistry/genetics/*metabolism | 3 | 13.0 |
Time Factors | 2 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Myasthenia Gravis/classification/*immunology | 2 | 100.0 |
Transgenes | 2 | 0.0 |
Agrin/genetics/metabolism | 2 | 100.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
